Advisory Services Network’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-112
| Closed | -$8K | – | 2705 |
|
|
2023
Q4 | $8K | Buy |
+112
| New | +$8K | ﹤0.01% | 2953 |
|
|
2023
Q2 | – | Sell |
-119
| Closed | -$8.75K | – | 2682 |
|
|
2023
Q1 | $8.75K | Buy |
119
+7
| +6% | +$515 | ﹤0.01% | 2933 |
|
|
2022
Q4 | $7.48K | Buy |
+112
| New | +$7.48K | ﹤0.01% | 2965 |
|
|
2021
Q3 | – | Sell |
-180
| Closed | -$15K | – | 2449 |
|
|
2021
Q2 | $15K | Buy |
+180
| New | +$15K | ﹤0.01% | 2625 |
|
|
2021
Q1 | – | Sell |
-260
| Closed | -$16K | – | 2371 |
|
|
2020
Q4 | $16K | Sell |
260
-3
| -1% | -$185 | ﹤0.01% | 2225 |
|
|
2020
Q3 | $15K | Buy |
+263
| New | +$15K | ﹤0.01% | 2215 |
|
|
2020
Q2 | – | Sell |
-340
| Closed | -$15K | – | 2016 |
|
|
2020
Q1 | $15K | Sell |
340
-123
| -27% | -$5.43K | ﹤0.01% | 2033 |
|
|
2019
Q4 | $30K | Sell |
463
-119
| -20% | -$7.71K | ﹤0.01% | 1794 |
|
|
2019
Q3 | $41K | Hold |
582
| – | – | ﹤0.01% | 1459 |
|
|
2019
Q2 | $41K | Sell |
582
-333
| -36% | -$23.5K | ﹤0.01% | 1457 |
|
|
2019
Q1 | $72K | Sell |
915
-18
| -2% | -$1.42K | 0.01% | 1103 |
|
|
2018
Q4 | $79K | Buy |
933
+11
| +1% | +$931 | 0.01% | 983 |
|
|
2018
Q3 | $158K | Sell |
922
-37
| -4% | -$6.34K | 0.01% | 824 |
|
|
2018
Q2 | $139K | Sell |
959
-3
| -0.3% | -$435 | 0.01% | 833 |
|
|
2018
Q1 | $99K | Buy |
962
+15
| +2% | +$1.54K | 0.01% | 1022 |
|
|
2017
Q4 | $81K | Buy |
947
+721
| +319% | +$61.7K | 0.01% | 1058 |
|
|
2017
Q3 | $19K | Hold |
226
| – | – | ﹤0.01% | 1420 |
|
|
2017
Q2 | $17K | Buy |
226
+29
| +15% | +$2.18K | ﹤0.01% | 1398 |
|
|
2017
Q1 | $13K | Buy |
+197
| New | +$13K | ﹤0.01% | 1378 |
|
|
2016
Q3 | $11K | Hold |
180
| – | – | ﹤0.01% | 1281 |
|
|
2016
Q2 | $13K | Hold |
180
| – | – | ﹤0.01% | 1130 |
|
|
2016
Q1 | $12K | Buy |
+180
| New | +$12K | ﹤0.01% | 1024 |
|